Florence Lhospice

Dr. Florence Lhospice is Chief Development Officer of Emergence Therapeutics. She previously served as Senior Director at Innate Pharma, where she led the ADC pre-clinical programs. While at Innate Pharma, Dr. Lhospice was head of chemistry, manufacturing and control processes (CMC) for 5 years, after which she was in charge of the development of an ADC technology for a site specific conjugation. Dr. Lhospice holds a PhD in Pharmacy from the Pharmacy School of University Joseph Fourier in Grenoble and the University of Montreal, a Masters degree from the University Claude Bernard in Lyon and the EM Lyon Business School and obtained a PhD in human pathology-oncology from the Medical School of the University of Aix-Marseille.